Alan Dietzek, MD
Vascular Surgery · Neptune, NJNPI 1134160435
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $17,121 of the $20,688 with a category attached, or 82.8%. It is spread thinly across 33 manufacturers, the largest accounting for just 23.7% — the pattern of someone who eats at a lot of different presentations.
Across 261 payments — averaging $79.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- W. L. Gore & Associates, Inc.$5K
- Penumbra, Inc.$4K
- Bard Peripheral Vascular, Inc.$3K
- Medtronic$2K
- Bolton Medical Inc$2K
- Boston Scientific$2K
- plus $4K from 27 others
Across 57 payments — averaging $1019.81 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Penumbra, Inc.$54K
- Bolton Medical Inc$4K
What the payments were for
- Consulting fees$4502%
- Speaking & faculty fees$2,40012%
- Travel & lodging$2751%
- Food & beverage$17,12183%
- Education$4422%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| W. L. Gore & Associates, Inc. | 37 | $4,901 |
| Penumbra, Inc. | 11 | $3,503 |
| Bard Peripheral Vascular, Inc. | 59 | $2,967 |
| Medtronic | 29 | $2,129 |
| Bolton Medical Inc | 22 | $1,727 |
| Boston Scientific | 27 | $1,550 |
| Inari Medical, Inc. | 7 | $576 |
| Shockwave Medical, Inc | 9 | $572 |
| Silk Road Medical, Inc. | 6 | $453 |
| Shape Memory Medical Inc. | 7 | $436 |
| Endologix LLC | 4 | $383 |
| Cook Medical LLC | 2 | $242 |
| Abbott | 5 | $144 |
| Getinge USA Sales, LLC | 2 | $112 |
| Philips North America LLC | 1 | $111 |
| Imperative Care, Inc | 4 | $103 |
| Lemaitre Vascular, Inc. | 4 | $100 |
| Davol Inc. | 1 | $98 |
| Angiodynamics, Inc. | 3 | $77 |
| Johnson & Johnson | 4 | $67 |
| Tactile Systems Technology Inc | 2 | $57 |
| Smith+Nephew | 2 | $51 |
| Stryker | 1 | $48 |
| Veryan Medical Incorporated | 1 | $45 |
| Bone Support Inc. | 1 | $44 |
| Flowphysix Inc | 1 | $38 |
| Kerecis Limited | 2 | $37 |
| Acera Surgical, Inc. | 2 | $37 |
| Cagent Vascular Inc | 1 | $19 |
| Cardiovascular Systems Inc. | 1 | $19 |
| Humacyte Global, Inc. | 1 | $18 |
| GE HealthCare | 1 | $14 |
| Venclose Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Indigo$2,547
- GORE VIABAHN VBX Balloon Expandable Endo$1,237
- ENDURANT IIS$962
- ENROUTE Transcarotid Neuroprotection System$878
- Lutonix Drug Coated Balloon$865
- GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis$776
- GORE EXCLUDER AAA Endoprosthesis$766
- Indigo System$741
- Grafts$558
- Relay Grafts$552
- AngioJet Ultra 5000A$450
- EXCLUDER Conformable AAA Endoprosthesis with Active Control$421
- Crosser iQ$410
- GORE TAG Thoracic Endoprosthesis$395
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$375
- ENROUTE Transcarotid Stent$355
- ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter$355
- HawkOne$339
- FLOWTRIEVER CATHETER, S$301
- CT THROMBECTOMY SYSTEM KIT$301
How this compares
$20,688 in reported general payments places this provider in the 80th percentile of 182 vascular surgery providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 13 | $7,234 |
| Cilostazol | 38 | $1,005 |
| ClopidogrelClopidogrel Bisulfate | 23 | $229 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $67 | $7,23413 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 182 vascular surgery providers in New Jersey.
Other vascular surgery in Neptune
- Habib KhanNeptune$26K
- Mohammad Nasir KhanNeptune$21K
- Steven EliasEnglewood$509K
- Michael WildermanHackensack$383K
- David O'ConnorHackensack$272K
- Joseph LombardiPomona$266K
- William BeckermanNew Brunswick$176K
- Neil PoulsenRockaway$148K
- Massimo NapolitanoWayne$147K
- Laurel HastingsCamden$98K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.